Thanks, Matt. Still some way to go w.r.t. ensuring that the SOTA in prostate-AI works just as well in a multiethnic, global population (>40 cities, 20 countries) and for population-based screening. And of course, we need more RCTs and standardization in imaging. Stay tuned for more results in 2025.